AIM
PCRX icon

Assured Investment Management’s Pacira BioSciences PCRX Stock Holding History

Assured Investment Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-18,664
Closed -$710K – 616
2019
Q1 		$710K Buy
18,664
+5,463
+41% +$213K 0.01% 470
2018
Q4 		$568K Buy
13,201
+10,754
+439% +$502K 0.02% 618
2018
Q3 		$120K Sell
2,447
-7,419
-75% -$321K ﹤0.01% 1019
2018
Q2 		$316K Buy
9,866
+7,284
+282% +$251K 0.01% 930
2018
Q1 		$80K Buy
+2,582
New +$91.9K ﹤0.01% 1067
2015
Q3 		– Sell
-1,725
Closed -$122K – 692
2015
Q2 		$122K Buy
+1,725
New +$136K ﹤0.01% 552

Other funds holding PCRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return